Patent ID: 11896682
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  C

Claim 36:
37. A compound of Formula (III):, wherein A is an antibody or antigen binding fragment thereof that binds MET and k is an integer from 1-30;
wherein the antibody or antigen-binding fragment thereof comprises three HCDRs in an HCVR having an amino acid sequence selected from the group consisting of SEQ ID NO: 2, 10, 18, 26, 34, 42, 50, 58, 66, 74, 82, 90, 98, 106, 114, 122, and 130; and three LCDRs in an LCVR having an amino acid sequence of SEQ ID NO: 138.